NSCLC ADENOCARCINOMA
Clinical trials for NSCLC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NSCLC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for NSCLC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: first human test of experimental drug begins
Disease control Recruiting nowThis is the first study in humans of an experimental drug called MGC028 for people with advanced solid tumors that have stopped responding to standard treatments. Researchers will test increasing doses in about 124 participants to find the highest safe amount and check for side e…
Matched conditions: NSCLC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug combo targets genetic weakness in tough cancers
Disease control Recruiting nowThis early-stage study is testing a new drug, IDE892, both alone and in combination with another drug called IDE397. It is for adults with advanced solid tumors that have a specific genetic change called MTAP deletion and have stopped responding to standard treatments. The main g…
Matched conditions: NSCLC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC